In this paper, three critical issues with the paper "A fuzzy set approach for R&D portfolio selection using a real options valuation model", coauthored by Wang and Hwang and published in Omega 2007 are addressed. Shortcomings of the original work are highlighted and corrective measures to...

Pharmaceutical drug Research and Development (R&D) outsourcing to contract research organizations (CROs) has experienced a significant growth in recent decades and the trend is expected to continue. A key question for CROs and firms in similar environments is which projects should be included in...